BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28329483)

  • 21. Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: a case-series of 16 patients.
    Hasson A; Navarrete-Dechent C; Nicklas C; de la Cruz C
    Indian J Dermatol Venereol Leprol; 2012; 78(4):448-53. PubMed ID: 22772615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actinic keratosis and squamous cell carcinoma: clinical and pathological features.
    Filosa A; Filosa G
    G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization.
    Rossi A; Garelli V; Pranteda G; Cardone M; Anzalone A; Fortuna MC; Di Nunno D; Mari E; De Vita G; Carlesimo M
    J Photochem Photobiol B; 2016 Sep; 162():72-76. PubMed ID: 27344021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses.
    Ingham AI; Weightman W
    Australas J Dermatol; 2014 Aug; 55(3):204-8. PubMed ID: 24627952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, dermoscopic and immunohistochemical assessment of actinic keratoses and evaluation of the effectiveness of diclofenac therapy with immunohistochemical analysis.
    Çayirli M; Köse O; Demiriz M
    Arch Dermatol Res; 2013 Jul; 305(5):389-95. PubMed ID: 23397597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of solar keratoses by regular sunscreen use.
    Thompson SC; Jolley D; Marks R
    N Engl J Med; 1993 Oct; 329(16):1147-51. PubMed ID: 8377777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of treating the field in actinic keratosis.
    Stockfleth E
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
    Moggio E; Arisi M; Zane C; Calzavara-Pinton I; Calzavara-Pinton P
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():161-165. PubMed ID: 27530375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Swanson N; Smith CC; Kaur M; Goldenberg G
    J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
    Ulrich M; Alarcon I; Malvehy J; Puig S
    Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indole 3-acetic acid-photodynamic therapy in the treatment of multiple actinic keratoses: A proof of concept pilot study.
    Grandi V; Baldi I; Cappugi P; Mori M; Pimpinelli N
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():17-22. PubMed ID: 27565032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypodium leucotomos supplementation in the treatment of scalp actinic keratosis: could it improve the efficacy of photodynamic therapy?
    Auriemma M; Di Nicola M; Gonzalez S; Piaserico S; Capo A; Amerio P
    Dermatol Surg; 2015 Aug; 41(8):898-902. PubMed ID: 26218723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis.
    Sinnya S; Tan JM; Prow TW; Primiero C; McEniery E; Selmer J; Østerdal ML; Soyer HP
    Br J Dermatol; 2016 Feb; 174(2):305-11. PubMed ID: 26499175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.
    Erlendsson AM; Karmisholt KE; Haak CS; Stender IM; Haedersdal M
    J Am Acad Dermatol; 2016 Apr; 74(4):709-15. PubMed ID: 26810403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses.
    Ulrich M; Krueger-Corcoran D; Roewert-Huber J; Sterry W; Stockfleth E; Astner S
    Dermatology; 2010; 220(1):15-24. PubMed ID: 19907131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
    Zane C; Facchinetti E; Rossi MT; Specchia C; Calzavara-Pinton PG
    Br J Dermatol; 2014 May; 170(5):1143-50. PubMed ID: 24506666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.